Carlsmed Inc [CARL] stock is trading at $16.21, up 9.90%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CARL shares have gain 36.91% over the last week, with a monthly amount glided 23.55%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Carlsmed Inc [NASDAQ: CARL] stock has seen the most recent analyst activity on August 18, 2025, when Truist initiated its Buy rating and assigned the stock a price target of $18. Previously, Piper Sandler started tracking the stock with Overweight rating on August 18, 2025, and set its price target to $18. On August 18, 2025, Goldman initiated with a Buy rating and assigned a price target of $19 on the stock. BTIG Research started tracking the stock assigning a Buy rating and suggested a price target of $21 on August 18, 2025. BofA Securities initiated its recommendation with a Buy and recommended $16 as its price target on August 18, 2025.
Carlsmed Inc [CARL] stock has fluctuated between $11.55 and $16.20 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. Carlsmed Inc [NASDAQ: CARL] shares were valued at $16.21 at the most recent close of the market. An investor can expect a potential return of 11.04% based on the average CARL price forecast.
Analyzing the CARL fundamentals
Carlsmed Inc [NASDAQ:CARL] reported sales of 44.75M for the trailing twelve months, which represents a growth of 98.39%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at -1.04%, Pretax Profit Margin comes in at -0.58%, and Net Profit Margin reading is -0.58%. To continue investigating profitability, this company’s Return on Assets is posted at -0.19, Equity is 0.83 and Total Capital is -0.38. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 15.05 points at the first support level, and at 13.90 for the second support level. However, for the 1st resistance point, the stock is sitting at 16.82, and for the 2nd resistance point, it is at 17.44.
Ratios To Look Out For
For context, Carlsmed Inc’s Current Ratio is 12.03. In addition, the Quick Ratio stands at 11.91 and the Cash Ratio stands at 10.56. Considering the valuation of this stock, the price to sales ratio is 9.63, the price to book ratio is 4.04.
Transactions by insiders
Recent insider trading involved B CAPITAL GROUP MANAGEMENT, L., 10% Owner, that happened on Jul 24 ’25 when 1.33 million shares were purchased. Director, Sidow Kevin completed a deal on Jul 24 ’25 to buy 13333.0 shares. Meanwhile, Director Mittendorff Robert II bought 1.33 million shares on Jul 24 ’25.
